Novel Therapeutic Agents and Innovative Delivery Systems Against Infectious Diseases
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 30 November 2025 | Viewed by 908
Special Issue Editor
Interests: drug delivery; medicinal chemistry; drug discovery and development; antimycobacterial agents; antiviral agents; tuberculosis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Innovative therapeutics against infectious diseases are urgently needed. The lack of a strong pipeline of anti-infective drugs, coupled with the rising prevalence of resistant and emerging pathogens, has led to a worldwide health crisis over the last decade, posing a serious threat to global health systems worldwide. To address these challenges, novel approaches to infectious disease drug development are required. This Special Issue sets out to explore cutting-edge advancements in the discovery of new novel therapeutic agents and innovative drug delivery systems against infectious diseases, particularly those targeting emerging and resistant pathogens. We aim to highlight breakthroughs in the development of small molecules, biologics, vaccines, and advanced drug delivery systems, such as nanocarriers, lipid-based formulations, and targeted delivery strategies.
We welcome the submission of original research articles and reviews that advance our understanding and treatment of infectious diseases through novel therapies and innovative delivery strategies. The aim is to bring together diverse perspectives from pharmaceutical sciences, including drug discovery, formulation chemistry, pharmacokinetics, and preclinical/clinical development, with a focus on translational research to meet unmet needs in the treatment of infectious diseases.
Dr. Sara Consalvi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- medicinal chemistry
- antibacterials
- antivirals
- antimicrobials
- drug resistance
- drug delivery
- drug candidate
- drug repurposing
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
